Company / Book Value per Share
ADMA Biologics, Inc. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$2.017
FY2025
5-year range
$0.451 / $2.017
FY2021-FY2025
Trend
+30.7%
vs FY2024
Sector context
#149 of 209
Health Care
What the data says
At $2.017, ADMA Biologics, Inc.'s book value per share ranks #149 of 209 in the Health Care sector. Book Value per Share has increased for 3 consecutive years, from $0.451 in FY2022 to $2.017 in FY2025.
Based on SEC 10-K filings.
$2.017 in FY2025 with a 5-year CAGR of +6.3%.
Improved from $0.61 to $2.017 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +64.8%
- 5-Year CAGR
- +6.3%
- 10-Year CAGR
- -
Sector benchmark
#149 of 209 in Health CareTop 71% of 209This company $2.017 Sector average $215.686
▼
-99.1% below sector average
Key checks
Key Insights
- ADMA Biologics, Inc.'s book value per share has grown for 3 consecutive years.
- 5-year CAGR of +6.3%, indicating consistent growth.
- In FY2025, book value per share increased 30.7% year-over-year.
- Ranks #149 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.37 (safe zone, above 2.9 threshold)
- Strong profit margin: 46.4%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.017 | +30.7% |
| FY2024 | $1.544 | +153.3% |
| FY2023 | $0.61 | +35.2% |
| FY2022 | $0.451 | -66.5% |
| FY2021 | $1.346 | -9.5% |
| FY2020 | $1.488 | +163.3% |
| FY2019 | $0.565 | +5.0% |
| FY2018 | $0.538 | +255.6% |
| FY2017 | -$0.346 | +16.9% |
| FY2016 | -$0.416 | -164.3% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026